Piroxicam Tablets Suppliers & Bulk Manufacturers
Available Forms: Tablets
Available Strengths: 10 mg,20 mg
Reference Brands: Feldene (USA/EU/UK), Brexidol (EU), Hotemin
Category:
Analgesic
Piroxicam Tablet is a medicine that is used for the treatment of Swelling, Stiffness And Joint Pain, Osteoarthritis, Rheumatoid Arthritis, Acute Gout, Postoperative Pain, Acute Musculoskeletal Conditions and other conditions.
Piroxicam Tablet contains Piroxicam as an active ingredient.
Piroxicam Tablet works by decreasing the production of prostaglandins that cause pain.
Piroxicam Tablets is available in Tablets
and strengths such as 10 mg,20 mg.
Sourced from GMP-certified and ISO-compliant manufacturers, this API meets
global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical
formulation and commercial manufacturing, Piroxicam Tablets is supplied in
bulk quantities with complete regulatory support including DMF, COA, and MSDS.
|
Technical Specifications & Supply Details
|
| Lead Time |
7 to 60 days (depending on batch size & schedule) |
| MOQ |
As per manufacturer’s batch size |
| COA |
Available with every batch |
| Regulatory Dossier / DMF |
Available upon request |
| Export Documentation |
FSC, COA, Manufacturing License, Product Permission |
| Standards |
IP, BP, USP |
| Certifications |
WHO-GMP, EU-GMP, USFDA (as applicable) |
Piroxicam Tablets can be exported to over 30 countries across Asia, Africa, Europe,
and Latin America. Flexible packaging, competitive pricing, and a verified supplier
network make Pharmatradz a trusted sourcing partner for pharmaceutical companies
and contract manufacturers worldwide.
Product Description:
Piroxicam Tablet is used for the treatment, control, prevention, & improvement of the following diseases, conditions and symptoms: · Swelling, Stiffness And Joint Pain · Osteoarthritis · Rheumatoid Arthritis · Acute Gout · Postoperative Pain · Acute Musculoskeletal Conditions
Piroxicam is used in the treatment of selected inflammatory conditions where long-term anti-inflammatory therapy is required. It is indicated for the management of chronic inflammatory disorders such as rheumatoid arthritis and osteoarthritis, and may also be used in conditions like primary dysmenorrhoea and postoperative pain when an inflammatory component is present. The medicine provides effective analgesic and anti-inflammatory action by reducing pain, swelling, and stiffness associated with these conditions.
Piroxicam acts primarily as an analgesic in situations where pain is driven by inflammation, making it particularly useful in musculoskeletal and joint-related disorders. Due to its pharmacological profile and potential safety considerations, regulatory authorities have carefully evaluated its clinical use. In 2007, the European Medicines Agency conducted a comprehensive review and recommended that piroxicam use be restricted mainly to the treatment of chronic inflammatory conditions. This recommendation was based on an assessment showing that the benefit-risk balance of piroxicam is most favorable when used in long-term inflammatory disorders rather than short-term pain management.
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Back to Listing